RecruitingPHASE1, PHASE2NCT07451613

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Studying Huntington disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Leslie Thompson
Intervention
hNSC-01(biological)
Enrollment
21 enrolled
Eligibility
18-65 years · All sexes
Timeline
20262031

Study locations (1)

Collaborators

California Institute for Regenerative Medicine (CIRM) · University of California, Irvine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07451613 on ClinicalTrials.gov

Other trials for Huntington disease

Additional recruiting or active studies for the same condition.

See all trials for Huntington disease

← Back to all trials